GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (MIL:PHIL) » Definitions » EPS (Diluted)

Philogen SpA (MIL:PHIL) EPS (Diluted) : €-0.73 (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA EPS (Diluted)?

Philogen SpA's Earnings per Share (Diluted) for the six months ended in Jun. 2024 was €-0.39. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.73.

Philogen SpA's EPS (Basic) for the six months ended in Jun. 2024 was €-0.39. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.73.

Philogen SpA's EPS without NRI for the six months ended in Jun. 2024 was €-0.42. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.79.

During the past 3 years, the average EPS without NRIGrowth Rate was 16.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Philogen SpA's highest 3-Year average EPS without NRI Growth Rate was 16.20% per year. The lowest was 16.20% per year. And the median was 16.20% per year.


Philogen SpA EPS (Diluted) Historical Data

The historical data trend for Philogen SpA's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA EPS (Diluted) Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
-0.37 -0.39 -0.13 -0.15

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only 0.05 -0.18 0.19 -0.34 -0.39

Competitive Comparison of Philogen SpA's EPS (Diluted)

For the Biotechnology subindustry, Philogen SpA's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Philogen SpA's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Philogen SpA's PE Ratio distribution charts can be found below:

* The bar in red indicates where Philogen SpA's PE Ratio falls into.



Philogen SpA EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Philogen SpA's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-6.161-0)/40.248
=-0.15

Philogen SpA's Diluted EPS for the quarter that ended in Jun. 2024 is calculated as

Diluted EPS (Q: Jun. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-15.516-0)/40.290
=-0.39

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Philogen SpA  (MIL:PHIL) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Philogen SpA EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Philogen SpA's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Philogen SpA Business Description

Traded in Other Exchanges
Address
Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

From GuruFocus